Oric Pharmaceuticals Inc
NASDAQ:ORIC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Oric Pharmaceuticals Inc
NASDAQ:ORIC
|
US |
|
Haulotte Group SA
PAR:PIG
|
FR |
|
C
|
CEL-SCI Corp
AMEX:CVM
|
US |
|
M
|
MFE-MEDIAFOREUROPE NV
MIL:MFEB
|
IT |
|
S
|
State Bank of India
LSE:SBID
|
IN |
|
Penske Automotive Group Inc
F:UA9
|
US |
|
J
|
J B Hunt Transport Services Inc
F:JB1
|
US |
|
G
|
Grenergy Renovables SA
MAD:GRE
|
ES |
|
Midi Utama Indonesia Tbk PT
IDX:MIDI
|
ID |
|
Applied DNA Sciences Inc
NASDAQ:APDN
|
US |
|
S
|
Stef SA
PAR:STF
|
FR |
Wall St Price Targets
ORIC Price Targets Summary
Oric Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
ORIC is 21.05 USD with a low forecast of 15.15 USD and a high forecast of 26.25 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ORIC's stock price target?
Price Target
21.05
USD
According to Wall Street analysts, the average 1-year price target for
ORIC is 21.05 USD with a low forecast of 15.15 USD and a high forecast of 26.25 USD.